Lawrence Erik Kurzius

Lawrence Erik Kurzius (chief executive) discloses dealings in 4 companies, chiefly Mccormick & Co Inc, Elanco Animal Health Inc and Cooper Companies, Inc. Over a trading history stretching from 25 January 2016 to 8 October 2026, the count stands at 92 filings.

On the open market, the record shows 8 purchases worth €2.5M and 5 sales worth €26.4M. Sales outweigh purchases by €23.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 40 share grants and 27 option exercises. 2026 to date brings 3 purchases and 1 sale.

In size, the median ticket on the buying side is €193k. As a share of market capitalisation, the median purchase stands at 0.0048%, based on 3 purchases. Clusters matter here: 8 out of 8 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 4 purchases show a median change of +17.0%, with the price up in 75% of them. They describe history only and say nothing certain about the share price ahead.

Most recently, on 9 October 2026, the filings show a share grant in Lamb Weston Holdings, Inc. The most recent open-market purchase was published on 17 September 2026, 34 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.